Clinical trial
A Phase I Study of DFP-14927 in Patients With Advanced Solid Tumors
NCT03943004 is registered in ClinicalTrials.gov with Delta-Fly Pharma, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of DFP-14927 in Patients With Advanced Solid Tumors
- Lead sponsor
- Delta-Fly Pharma, Inc.
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- September 30, 2019
- Completion date
- June 1, 2026
- Enrollment
- 30 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, solid tumor